Vaccine Therapy With or Without Sargramostim in Treating Patients With Cancer - Contacts and Locations

Home

Vaccine Therapy With or Without Sargramostim in Treating Patients With Cancer

This study is ongoing, but not recruiting participants.

Study NCT00009958. Last updated on July 23, 2008. Information provided by National Cancer Institute (NCI)

Please refer to this study by its ClinicalTrials.gov identifier: NCT00009958

Locations


United States, District of Columbia
	Lombardi Cancer Center
	Washington, District of Columbia, United States, 20007

Sponsors and Collaborators

Lombardi Cancer Research Center

National Cancer Institute (NCI)

Investigators


Study Chair:	John L. Marshall, MD	Lombardi Cancer Research Center